Meningococcal bacterial DNA load at presentation correlates with disease severity
Open Access
- 1 January 2002
- journal article
- acute paediatrics
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (1) , 44-46
- https://doi.org/10.1136/adc.86.1.44
Abstract
Aims: To determine bacterial loads in meningococcal disease (MCD), their relation with disease severity, and the factors which determine bacterial load. Methods: Meningococcal DNA quantification was performed by the Taqman PCR method on admission and sequential blood samples from patients with MCD. Disease severity was assessed using the Glasgow Septicaemia Prognostic Score (GMSPS, range 0–15, severe disease ≥8). Results: Median admission bacterial load was 1.6 × 106 DNA copies/ml of blood (range 2.2 × 104 to 1.6 × 108). Bacterial load was significantly higher in patients with severe (8.4 × 106) compared to milder disease (1.1 × 106, p = 0.018). This difference was greater in septicaemic patients (median 1.6 × 107 versus 9.2 × 105, p < 0.001). Bacterial loads were significantly higher in patients that died (p = 0.017). Admission bacterial load was independent of the duration of clinical symptoms prior to admission, with no difference between the duration of symptoms in mild or severe cases (median, 10.5 and 11 hours respectively). Bacterial loads were independent of DNA elimination rates following treatment. Conclusion: Patients with MCD have higher bacterial loads than previously determined with quantitative culture methods. Admission bacterial load is significantly higher in patients with severe disease (GMSPS ≥8) and maximum load is highest in those who die. Bacterial load is independent of the duration of clinical symptoms or the decline in DNA load.Keywords
This publication has 13 references indexed in Scilit:
- Evaluation of CMV viral load using TaqMan??? CMV quantitative PCR and comparison with CMV Antigenemia in heart and lung transplant recipientsTransplantation, 2001
- Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS)Clinical and Experimental Immunology, 2000
- An Interleukin?1 Genotype Is Associated with Fatal Outcome of Meningococcal DiseaseThe Journal of Infectious Diseases, 2000
- Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNAFEMS Immunology & Medical Microbiology, 2000
- Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shockThe Lancet, 1999
- Meningococcal disease in AfricaPathogens and Global Health, 1997
- Genetic influence on cytokine production and fatal meningococcal diseaseThe Lancet, 1997
- Correlation between Proinflammatory Cytokines and Antiinflammatory Mediators and the Severity of Disease in Meningococcal InfectionsThe Journal of Infectious Diseases, 1995
- Validation of the Glasgow Meningococcal Septicemia Prognostic ScoreCritical Care Medicine, 1991
- Magnitude of bacteremia and complement activation duringNeisseria meningitidis infection: Study of two co-primary cases with different clinical presentationsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984